Merck Covid-19 Pill

Merck Covid-19 Pill

Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on 16 November, 2021. PHOTO: Pfizer/Handout via REUTERS

EU drug regulator OKs Pfizer Covid pill for high-risk patients

EU health commissioner Stella Kyriakides said the bloc was now making good progress on lining up treatments, which she described as a second line of defence after vaccines

An advisory encouraging people to maintain social distancing and weara a protective face mask is seen, after the government allowed domestic flight services to resume from coming Monday, during an extended nationwide lockdown to slow the spread of the coronavirus disease (Covid-19), at the Indira Gandhi International (IGI) Airport, in New Delhi, India, May 23, 2020. REUTERS/Anushree Fadnavis

India allows emergency use of Merck's Covid-19 pill, two more vaccines

An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Photo: Reuters

India committee recommends EUA for Merck's Covid-19 pill, two other vaccines - report

A woman carries her luggage amid the coronavirus disease (Covid-19) pandemic at the central station in Berlin, Germany, 22 December, 2021. PHOTO: REUTERS/Annegret Hilse

Vaccines, pills and data offer some Christmas cheer in face of Omicron advance

A view of the Merck & Co. campus in Linden, New Jersey 9 March, 2009. PHOTO: REUTERS/Jeff Zelevansky

Japan health panel approves Merck's oral Covid-19 treatment

Photo :Collected

Philippines approves Merck's Covid-19 pill for at-risk patients

Photo :Collected

France cancels order for Merck's Covid-19 antiviral drug

Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Photo :Reuters

US FDA set to authorize Pfizer, Merck Covid-19 pills this week - Bloomberg News

Photo :Collected

Merck's Covid-19 pill significantly less effective in new analysis

Photo :Collected

EU recommends Merck Covid-19 pill for adults at risk of severe illness

Photo :Collected

Merck expects Covid pill to reach rich and poor countries simultaneously

In this undated file image provided by Merck & Co. shows their new antiviral medication. The pharmaceutical Merck has agreed to allow other drugmakers worldwide to make its Covid-19 treatment, the first pill that has been shown to be effective against the disease, in a move aimed at helping millions of people in poorer countries access to the drug. In a statement on Wednesday, Oct. 27, 2021, the UN-backed Medicines Patent Pool said it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics. (Merck & Co. via AP, File)

Merck agrees to let other drug makers make its Covid pill

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid

Merck Covid-19 pill sparks calls for access for lower income countries